Serum albumin-enhanced screening: A triage strategy and predictive model for OGTT in community-managed patients with coronary heart disease
Diabetes & Vascular Disease Research · 2026-07 · 23 (4)
DOI: 10.1177/14791641261474034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes & Vascular Disease Research, online erschienen am 27.07.2026. Verfasst von Chumin Ni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shantou Clinical Medical College (Shantou Central Hospital), Jinan University, Shantou, Guangdong, China. Hauptthemen laut MEDLINE: Coronary Disease, Blood Glucose, Triage, Serum Albumin, Human. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Guangdong Medical Research Foundation, Shantou Medical and Technology Plan of 2025.
Abstract (Originalsprache)
Background
Patients with coronary heart disease (CHD) are at high risk of undiagnosed diabetes. Reliance on standard fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) may lead to underdiagnosis, highlighting the need for optimized screening strategies.
Methods
Using data from the National Health and Nutrition Examination Survey (NHANES) cycles 2007–2016, we analyzed 287 patients with CHD and 8,904 non-CHD controls without pre-existing diabetes. A two-tier protocol was implemented, consisting of initial FPG/HbA1c screening followed by OGTT. A prediction model was derived to identify individuals at high risk for OGTT-dependent diabetes.
Results
Patients with CHD had a 3.4-fold higher weighted prevalence of newly diagnosed diabetes than controls (22.1% [95% CI, 16.5%–28.8%] vs. 6.5% [95% CI, 5.8%–7.2%]). Initial FPG/HbA1c screening missed 32 of 64 diabetes cases (50.0%), which were detectable only by OGTT. The albumin-enhanced model (HbA1c + FPG + albumin) demonstrated robust discriminatory capacity (AUC 0.823) and provided significant incremental value over the HbA1c + FPG model, with an integrated discrimination improvement of 0.0611 and net reclassification improvement of 0.1562 (both P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Shantou Clinical Medical College (Shantou Central Hospital), Jinan University, Shantou, Guangdong, China.
- Department of Cardiac Rehabilitation, Shantou Clinical Medical College (Shantou Central Hospital), Jinan University, Shantou, Guangdong, China.
- Department of Emergency Medicine, Shantou Clinical Medical College (Shantou Central Hospital), Jinan University, Shantou, Guangdong, China.
ORCID-Profile: Weidai Zhang
Förderung
- Guangdong Medical Research Foundation
- Shantou Medical and Technology Plan of 2025
Zitieren
APA
Ni, C., Zhao, X., Liu, X., Zhao, K., & Zhang, W. (2026). Serum albumin-enhanced screening: A triage strategy and predictive model for OGTT in community-managed patients with coronary heart disease. Diabetes & Vascular Disease Research, 23(4). https://doi.org/10.1177/14791641261474034
Vancouver
Ni C, Zhao X, Liu X, Zhao K, Zhang W. Serum albumin-enhanced screening: A triage strategy and predictive model for OGTT in community-managed patients with coronary heart disease. Diabetes & Vascular Disease Research. 2026;23(4). doi:10.1177/14791641261474034
BibTeX
@article{Ni2026,
author = {Ni, Chumin and Zhao, XianWu and Liu, Xueying and Zhao, Kaixun and Zhang, Weidai},
title = {Serum albumin-enhanced screening: A triage strategy and predictive model for OGTT in community-managed patients with coronary heart disease},
journal = {Diabetes & Vascular Disease Research},
year = {2026},
volume = {23},
number = {4},
doi = {10.1177/14791641261474034}
}
EUVIMED